JPMORGAN CHASE & CO - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366J900. A total of 5 filers reported holding PTC THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$741,000
-71.4%
18,500
-69.9%
0.00%
Q2 2021$2,595,000
-10.7%
61,4000.0%0.00%
Q1 2021$2,907,000
+126.0%
61,400
+125.7%
0.00%
Q3 2020$1,286,000
+67.7%
27,200
+58.1%
0.00%
Q1 2020$767,000
-52.3%
17,200
-49.7%
0.00%
Q3 2018$1,607,000
+31.9%
34,200
-24.0%
0.00%
Q1 2018$1,218,000
+21.7%
45,000
-25.0%
0.00%
Q4 2017$1,001,00060,0000.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
PURA VIDA INVESTMENTS, LLC 73,100$2,928,0000.17%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
JANE STREET GROUP, LLC 8,400$337,0000.00%
JPMORGAN CHASE & CO 18,500$741,0000.00%
SIMPLEX TRADING, LLC 11,400$456,0000.00%
View complete list of PTC THERAPEUTICS INC shareholders